Scaling Advanced Therapies: Dynamic Scheduling for Growth and Capacity

Dynamic Scheduling for Advanced Therapies: Scaling from Clinical to Commercial | Phacilitate x Emerson As advanced therapy organisations move from clinical development to commercial manufacturing, production scheduling gets harder. Capacity constraints, shifting demand, resource availability and process variability all put pressure on the ability to scale. In this on-demand webinar, hosted by Phacilitate on behalf of Emerson, a panel of industry experts discuss how dynamic scheduling is helping advanced therapy manufacturers gain visibility, evaluate capacity and adapt to changing production conditions. Drawing on real-world experience with Emerson’s DeltaV Real-Time Scheduling technology, the panel also explore applications for QC lab scheduling. In this session: ✓ How manufacturers are tackling scheduling challenges as production scales ✓ The role of dynamic scheduling in balancing resources, capacity and changing priorities ✓ Lessons from capacity analysis to support growth planning and investment decisions ✓ Strategies for building schedule resilience and responding to disruption ✓ Key considerations when moving from clinical-scale to commercial manufacturing Who should watch: Manufacturing operations leaders, production planners and schedulers, supply chain and operational excellence professionals, advanced therapy manufacturing leaders, digital transformation and manufacturing systems professionals, and QC lab managers. Panelists: 🔹 Keith Hope, Life Science Solution Consultant, Emerson 🔹 Christian Berg, Sr. Life Science Solution Consultant, Emerson 🔹 Olivia Farrell, Associate Director, CGT Site Production Scheduling, Vertex Pharmaceuticals 🔹 Steven Bengis, Director of Manufacturing Engineering, Operational and Automation Technology, Kite Pharma Originally broadcast on Thursday 22nd October 2026. 🔗 Find out more about Emerson’s DeltaV Real-Time Scheduling at Phacilitate Advanced Therapies Week 2027: https://bit.ly/4e9a3Ph #CellAndGeneTherapy #AdvancedTherapies #CGT #BiopharmaManufacturing #ProductionScheduling #DigitalTransformation #Phacilitate #Emerson